German Cannabis Legalization Fuels Surge in Weed Stocks

March 23, 2024 · MG Magazine

Cannabis stocks soared Friday on the news Germany’s parliament legalized cannabis for personal possession and use.

Canopy Growth Corporation’s stock (NASDAQ: CGC) surged a remarkable 39 percent, capping a weekly gain of more than 106 percent. Others on the NASDAQ, including Aurora Cannabis Inc. (ACB, up 26.6 percent), SNDL Inc. (SNDL, up 21.5 percent), Tilray Brands Inc. (TLRY, up 18.5 percent), and Cronos Group Inc. (CRON, up 9.2 percent), also witnessed substantial increases in share prices.

Under the new law, which will take effect April 1, adults ages 18 and older may possess up to 25 grams of cannabis for personal use and store up to 50 grams at home. The law also permits cultivation of up to three cannabis plants for personal use and limited public consumption. Beginning July 1, specialized “cannabis clubs” will be allowed to grow and dispense cannabis on a limited basis.

The legislative shift opens significant opportunities for businesses that operate in Germany, as Canopy does through its German vaporizer brand Storz & Bickel and its Canopy Medical pharmaceutical products brand.

“This legislation represents a very important and long-overdue step to end the criminalization of cannabis in Germany and sets an important example for the whole of Europe,” said Jürgen Bickel, managing director at Storz & Bickel. “With more than 20 years working in the cannabis industry, constantly advocating for legalization in Germany, I’m proud that consumers will now have a safe and legal environment for cannabis consumption.”

Germany’s declassification of cannabis as a narcotic is part of a wider global reform movement, recently spotlighted by U.S. Vice President Kamala Harris’s critique of America’s marijuana policies. Harris and President Joe Biden have called for the Drug Enforcement Administration to reconsider cannabis’s classification to reflect a more nuanced understanding of the plant’s uses and impacts. The agency is in the middle of a review process many in the industry believe will result in a loosening of restrictions in the United States. (Full Story)

In categories:Business International
Tags:
Next Post

The UK's Cannabis Market is Worth Over $3.3 Billion a Year, Will Cancer Headlines Push Legalization Forward in England?

As NPR reported, Catherine, Princess of Wales, has cancer, she announced in a video message released by Kensington Palace on Friday, and is in the early stages of chemotherapy. In the video, the former Kate Middleton, 42, said the diagnosis…
Read
Previous Post

Report Reveals Europe’s Cannabis and Cocaine Capitals, Dutch Cities Reign Supreme

A new report reveals the cities in Europe with the highest concentrations of cannabis and cocaine use, based on sewage surveys. Perhaps unsurprisingly, Dutch cities including Amsterdam and Rotterdam took home some of the top spots for the cities with the highest…
Read
Random Post

MJ Unpacked Bets Big and Wins on Blend of Business and Culture

The evolution of the cannabis market has seen a number of B2B trade shows and conferences pop up throughout the country. The vast majority offer a fairly standard mix of panels, exhibits, and cocktail hours targeted at professionals across the…
Read
Random Post

Florida Marijuana Legalization Campaign Nears Signature Total Needed For Ballot Access

An industry-backed marijuana reform campaign has so far collected more than 70 percent of the signatures it needs to put a legalization initiative before voters on the 2024 ballot. The Florida Division of Elections updates petition counts on the measure…
Read
Random Post

Edibles Consumers Desire High-Potency Product Packaging

Edibles are an invaluable segment of the cannabis industry. From classic THC-infused brownies to flavorful fruit-filled gems, edibles have captivated the imagination of medical patients and recreational consumers across all walks of life. In sports, former heavyweight foes Evander Holyfield and Mike…
Read
Random Post

FDA’s inaction on CBD regulations means more marijuana questions for Congress

The U.S. Food and Drug Administration’s announcement Thursday that it won’t regulate products containing CBD and will instead pass that buck to Congress means the preservation of the current, uneasy status quo for now. It will also mean more work…
Read